GCIA
APLS

Gabelli & Co Investment Advisers’s Apellis Pharmaceuticals APLS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200,600
Closed -$8.07M – 321
2026
Q1 		$8.07M Buy
+200,600
New +$4.32M 1.2% 24

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's APLS Position: Q2 2026 in Review

Gabelli & Co Investment Advisers sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 200,600 shares — an estimated $8.07M sold.

Gabelli & Co Investment Advisers first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $8.07M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Gabelli & Co Investment Advisers reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 200,600 Apellis Pharmaceuticals shares in Q2 2026, an estimated $8.07M.
  • Gabelli & Co Investment Advisers first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Apellis Pharmaceuticals position peaked at $8.07M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.